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ABSTRACT 
Liver cancer has become one of the major types of cancer with high mortality and liver 
cancer is not responsive to the current cytotoxic agents used in chemotherapy. The purpose of 
this study was to examine the in vitro cytotoxicity of goniothalamin on human 
hepatoblastoma HepG2 cells and normal liver Chang cells. The cytotoxicity of goniothalamin 
against HepG2 and liver Chang cell was tested using MTT cell viability assay, LDH leakage 
assay, cell cycle flow cytometry PI analysis, BrdU proliferation ELISA assay and trypan blue 
dye exclusion assay. Goniothalamin selectively inhibited HepG2 cells [IC 50 = 4.6 (±0.23) 
μM in the MTT assay; IC 50 = 5.20 (±0.01) μM for LDH assay at 72 hours], with less 
sensitivity in Chang cells [IC 50 = 35.0 (±0.09) μM for MTT assay; IC 50 = 32.5 (±0.04) μM 
for LDH assay at 72 hours]. In the trypan blue dye exclusion assay, the Viability Indexes 
were 52 ± 1.73% for HepG2 cells and 62 ± 4.36% for Chang cells at IC 50 after 72 hours. 
Cytotoxicity of goniothalamin was related to inhibition of DNA synthesis, as revealed by the 
reduction of BrdU incorporation. At 72 hours, the lowest concentration of goniothalamin (2.3 
μL) retained 97.6% of normal liver Chang cells proliferation while it reduced HepG2 cell 
proliferation to 19.8% as compared to control. Besides, goniothalamin caused accumulation 
of hypodiploid apoptosis and different degree of G2/M arrested as shown in cell cycle 
analysis by flow cytometry. Goniothalamin selectively killed liver cancer cell through 
suppression of proliferation and induction of apoptosis. These results suggest that 
goniothalamin shows potential cytotoxicity against hepatoblastoma HepG2 cells.  
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